InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 324578

Friday, 06/21/2019 11:33:14 PM

Friday, June 21, 2019 11:33:14 PM

Post# of 345964
Has John Springs Stafford been Avid Bioservices shareholders best interests in mind or would his interests be more aligned with Merck partners trying to sneak PS Targeting IP in house?

How many believe Merck do not advance certain programs properly?

Avid client Acumen (Goure) even agrees and with PS Targeting? I don't trust Merck at all

_______

“We were concerned that Merck wasn’t advancing our program as fast as we thought they should have,” Goure said.

https://medcitynews.com/2013/05/after-a-restructure-and-an-axed-merck-deal-acumen-gains-20m-for-novel-alzheimers-drug/

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News